GeneDx Holdings Corp.
(WGS)Financial Statements · SEC EDGAR XBRL
Revenue
$427.5M
+40.0%
Net Income
-$21.0M
+59.8%
EPS
$-0.73
+62.4%
Gross Margin
69.7%
Op. Income
-$13.1M
+43.7%
FCF
$14.3M
+142.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)